Health Care Rounds
#78: Our Take, October 28, 2019
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:43
- Mas informaciones
Informações:
Sinopsis
In this week’s Our Take, we’re covering the latest events in Biogen, involving their second life for aducanumab. To sign up for the weekly email brief, click here. Other briefs include:California releases its first report on drug pricing, in an effort to improve transparency.Bristol-Myers Squibb-Pfizer Alliance is collaborating with Fitbit for atrial fibrillation detection.Amazon is partnering with City of Hope to provide cancer support services to U.S. Amazon employees and their families.Hackensack Meridian Health and Englewood Health have signed a definitive merger agreement.RWJBarnabas Health has signed a non-binding letter of intent to acquire Trinitas Regional Medical Center and its affiliates.Drug distributors McKesson, AmerisourceBergen, and Cardinal Health are discussing an agreement with state and local authorities to settle thousands of opioid-related lawsuits for $18 billion. About Darwin Research GroupDarwin Research Group Inc. provides advanced market intelligence and in-depth customer insights t